Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition

A technology of fatty acid ester and naringenin, which is applied in the application field of anti-platelet aggregation, can solve the problems such as the literature that has not found the 5-hydroxyl esterification of naringenin, and achieves improved druggability, high yield, and improved drug resistance. effective effect

Active Publication Date: 2015-03-04
WEIFANG MEDICAL UNIVERSITY
View PDF12 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] However, so far, no literature on the esterification of the 5-hydroxyl group of naringenin has been found, and t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition
  • Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition
  • Naringenin fatty acid ester and preparation method thereof as well as pharmaceutical composition with naringenin fatty acid ester as active component and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0067] Example 1

[0068] Synthesis of Naringenin-5-O-Acetate

[0069] (1) Synthesis of 7,4’-O,O-dibenzylnaringenin

[0070] Naringenin (0.01mol, 2.72g) is dissolved in anhydrous N,N-dimethylformamide at a concentration of 0.3mol / L under the protection of nitrogen, and K is added at a concentration of 0.6mol / L 2 CO 3 (0.02mol, 2.76g), stirring at room temperature 25℃ for 1 hour, then slowly adding benzyl bromide (0.02mol, 2.40mL) with a concentration of 0.6mol / L under stirring, after the addition is complete, heating to 40℃ and stirring for reaction . The reaction progress was monitored with a GF254 silica gel thin layer chromatography plate, and the developing solvent: ethyl acetate / acetone / glacial acetic acid (6:6:1.5). After 4 hours of reaction, the naringenin spots disappeared and the benzylation reaction was complete. The reaction solution was poured into ice water, adjusted to pH=6 with 10wt% acetic acid aqueous solution, filtered, and the filter cake was washed with water u...

Example Embodiment

[0080] Example 2

[0081] Synthesis of Naringenin-5-O-Propionate

[0082] (1) Synthesis of 7,4’-O,O-dibenzylnaringenin

[0083] Naringenin (0.01mol, 2.72g) is dissolved in anhydrous N,N-dimethylformamide at a concentration of 0.05mol / L under the protection of nitrogen, and K is added at a concentration of 0.1mol / L 2 CO 3 (0.02mol, 2.76g), stirring at room temperature 25℃ for 1 hour, and then slowly adding benzyl bromide (0.02 mol, 2.40mL) with a concentration of 0.1mol / L under stirring. After the addition, the temperature is raised to 100℃ and the reaction is stirred. . The reaction progress was monitored with a GF254 silica gel thin layer chromatography plate, and the developing solvent: ethyl acetate / acetone / glacial acetic acid (6:6:1.5). After 6 hours of reaction, the naringenin spots disappeared and the benzylation reaction was complete. The reaction solution was poured into ice water, adjusted to pH=6 with 10wt% acetic acid aqueous solution, filtered, and the filter cake was ...

Example Embodiment

[0093] Example 3

[0094] Synthesis of Naringenin-5-O-n-Butyrate

[0095] (1) Synthesis of 7,4’-O-dibenzylnaringenin

[0096] Naringenin (0.01mol, 2.72g) is dissolved in anhydrous N,N-dimethylformamide at a concentration of 0.5mol / L under the protection of nitrogen, and K is added at a concentration of 1.0mol / L 2 CO 3 (0.02mol, 2.76g), stirring at room temperature 25°C for 1 hour, and then slowly adding benzyl bromide (0.02mol, 2.40mL) dropwise at a concentration of 1.0mol / L under stirring. After the addition, the reaction was stirred at 10°C. The reaction progress was monitored with a GF254 silica gel thin layer chromatography plate, and the developing solvent: ethyl acetate / acetone / glacial acetic acid (6:6:1.5). After 5 hours of reaction, the naringenin spots disappeared and the benzylation reaction was complete. The reaction solution was poured into ice water, adjusted to pH=6 with 10wt% acetic acid aqueous solution, filtered, and the filter cake was washed with water until it w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Login to view more

Abstract

The invention discloses a naringenin fatty acid ester. The naringenin fatty acid ester is naringenin fatty acid ester-5-O-fatty acid ester obtained by esterification of the fifth potential hydroxyl of naringenin. The invention also discloses a method for preparing the naringenin fatty acid ester-5-O-fatty acid ester, a pharmaceutical composition prepared with the naringenin fatty acid ester-5-O-fatty acid ester as the active component and an application of the pharmaceutical composition in inhibition of ADP, AA and collagen-induced platelet aggregation as well as cardiovascular diseases caused by platelet aggregation.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry, in particular to naringenin-5-O-fatty acid ester, a preparation method thereof, a pharmaceutical composition containing the compound as an active ingredient, and their application in anti-platelet aggregation. Background technique [0002] Naringenin is a kind of natural flavonoids, which widely exists in natural plants such as Citrus aurantium, Juhong, peach leaf, and Smilax, and has low toxic and side effects, and the extraction and separation process is mature and simple. Naringenin is the aglycone of naringin, which belongs to dihydroflavonoids, has antibacterial, anti-inflammatory, free radical scavenging, anti-oxidation, cough and expectorant, blood lipid lowering, anti-cancer and anti-tumor, antispasmodic and choleretic, preventive And treatment of liver disease, inhibition of platelet aggregation, anti-atherosclerosis, etc., can be widely used in medicine, food and other field...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D311/32A61K31/352A61P7/02A61P9/00
CPCC07D311/32
Inventor 段煜
Owner WEIFANG MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap